Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Fetal Growth Retardation: early-phase trial registry
1 of 4 indexed Fetal Growth Retardation trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #4,115 of 28,707 conditions by registered trial count.
4 US clinical trials · 1 currently recruiting · #4,115 of 28,707 conditions by registered trial count
Fetal Growth Retardation: 4 US clinical trials tracked, 1 recruiting.
Fetal Growth Retardation is the subject of 4 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Medicem Technology s.r.o., running 1 of these trials.
Enrollment posture brief
Registry condition fetal-growth-retardation
OPEN 1 | RECR 25% | LATE 0 | EARLY 1 | RANK #4115 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Abdominal Cancer (25% recruiting · 8 trials)
Fetal Growth Retardation lists 1 open slots (25% of 4 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Fetal Growth Retardation on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Fetal Growth Retardation is recruiting below its size-band peers.
1 of 4 indexed trials (25%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
4 total, page 1 of 1
Selective Fetal Growth Restriction in Monochorionic Twins - an International Investigation
Leiden University Medical Center
NCT05952583
Dilapan-S®: A Multicenter US E-registry
Medicem Technology s.r.o.
NCT04451109
Acute Effects of Maternal Exercise and the Growth Restricted Pregnancy
University of Tennessee Graduate School of Medicine
NCT06039319
Placental Lesions in Fetal Growth Restrictions
University of Wisconsin, Madison
NCT04839185
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Fetal Growth Retardation records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Fetal Growth Retardation trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Fetal Growth Retardation page
4 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Fetal Growth Retardation trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Medicem Technology s.r.o. sponsors the most Fetal Growth Retardation trials on record, review their full trial history before evaluating a specific study. See Medicem Technology s.r.o.'s trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Fetal Growth Retardation condition card totals 4 registered trials; most-linked intervention Ferumoxytol infusion; top US site state Wisconsin. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.